FDA Medical devices recall ·

Affixus Antegrade Femoral Nailing System Product Name: Affixus Antegrade… recall

Recall number
Z-0967-2026
Date
(initiated December 2, 2025)
Company / brand
Zimmer, Inc.
1800 W Center St, Warsaw, IN, United States
Category
Medical devices › Class II
Classification
Class II
Status
Ongoing
Units affected
22
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Brand Name: Affixus Antegrade Femoral Nailing System Product Name: Affixus Antegrade Femoral Nails Model/Catalog Number: 815509320 Software Version: N/A Product Description: Affixus 9 mm, Length 320 mm, Right, Trochanteric Nail Component: N/A

Why was it recalled?

Affected implants may have undersized distal diameter along length of the shaft, which could lead to implant fatigue fracture. Potential health risk if implant fatigue fracture occurs include adverse local tissue reaction, pain or ache, non-union or malunion, or tissue damage necessitating surgical intervention.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot Code: Model No 815509320 ; UDI-DI (01)00887868143526(17)340820(10)66717551 ; Lot Number 66717551 Model No 815509320 ; UDI-DI (01)00887868143526(17)340821(10)66884561; Lot Number 66884561

Distribution

US Nationwide distribution in the states of AL, AZ, CA, FL, IN, KY, MA, MO, MT, NC, NM, RI, TX, UT.

States: Alabama Arizona California Florida Indiana Kentucky Massachusetts Missouri Montana North Carolina New Mexico Rhode Island Texas Utah

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (medical devices), recall Z-0967-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.